Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Gamifant (emapalumab-lzsg) for Primary Haemophagocytic Lymphohistiocytosis

Gamifant® (emapalumab-lzsg) is a monoclonal antibody indicated to treat primary haemophagocytic lymphohistiocytosis in paediatric and adult patients. Photo: Business Wire.



  • Gamifant
  • Gamifant
  • Gamifant
Close
Close
Close

Go Top